GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

AFT Pharmaceuticals AFT.NZ · NZD

Health Care · NZX · 🇳🇿 New Zealand

Compare

4.50

-2.17%

Close of 9 Nov 2026, in NZD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in NZD, from our data supplier.

FY2026

Revenue

NZD 256.6m

FY2017FY2026

Net income

NZD 14.8m

FY2017FY2026

Free cash flow

−NZD 12.0m

FY2017FY2026

Shareholders' equity

NZD 111.1m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueNZD 256.6mNZD 205.5mNZD 194.0mNZD 156.6mNZD 130.3mNZD 113.1mNZD 105.6mNZD 85.1mNZD 81.2mNZD 69.2m
Gross profitNZD 111.4mNZD 89.2mNZD 86.9mNZD 73.0mNZD 61.8mNZD 48.7mNZD 48.3mNZD 40.7mNZD 35.3mNZD 26.0m
Research and developmentNZD 11.2mNZD 11.5mNZD 8.1mNZD 5.6mNZD 5.5mNZD 3.4mNZD 2.0mNZD 2.6mNZD 8.2mNZD 11.2m
Operating incomeNZD 25.0mNZD 11.7mNZD 20.3mNZD 19.7mNZD 20.4mNZD 10.7mNZD 11.5mNZD 6.6m−NZD 8.6m−NZD 14.9m
Net incomeNZD 14.8mNZD 12.0mNZD 15.6mNZD 10.7mNZD 19.8mNZD 7.8mNZD 12.7m−NZD 3.4m−NZD 13.6m−NZD 18.4m
Diluted earnings per share0.140.110.140.100.310.070.11-0.03-0.13-0.18

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsNZD 218.6mNZD 169.8mNZD 165.3mNZD 148.1mNZD 127.3mNZD 105.1mNZD 87.1mNZD 63.6mNZD 56.6mNZD 58.3m
Cash and short-term investmentsNZD 10.3mNZD 11.1mNZD 12.0mNZD 4.7mNZD 7.9mNZD 3.2mNZD 6.1mNZD 6.9mNZD 6.8mNZD 15.9m
Total liabilitiesNZD 108.7mNZD 72.7mNZD 77.5mNZD 74.8mNZD 65.0mNZD 68.5mNZD 69.8mNZD 58.5mNZD 49.3mNZD 38.9m
DebtNZD 54.5mNZD 30.0mNZD 32.2mNZD 38.0mNZD 40.5mNZD 42.2mNZD 47.2mNZD 41.8mNZD 30.7mNZD 23.4m
Shareholders' equityNZD 111.1mNZD 97.6mNZD 87.8mNZD 73.3mNZD 62.3mNZD 36.6mNZD 17.3mNZD 5.1mNZD 7.3mNZD 19.5m
Shares outstanding105m105m109m105m64m106m119m99m105m105m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−NZD 11.8mNZD 13.2mNZD 28.9mNZD 11.6mNZD 14.2mNZD 750,000NZD 14.9mNZD 1.1m−NZD 9.2m−NZD 19.1m
Capital spending−NZD 116,843−NZD 7.0m−NZD 9.5m−NZD 197,000−NZD 329,000−NZD 6.2m−NZD 6.6m−NZD 140,000−NZD 70,000−NZD 122,000
Free cash flow−NZD 12.0mNZD 6.2mNZD 19.3mNZD 11.4mNZD 13.8m−NZD 5.5mNZD 8.3mNZD 927,000−NZD 9.2m−NZD 19.2m
Dividends paid−NZD 1.9m−NZD 1.7m−NZD 1.2m——−NZD 188,000−NZD 566,000−NZD 134,000−NZD 412,000−NZD 412,000

Latest quarters

By quarter end

Mar 2026Sept 2025Mar 2025Sept 2024Mar 2024Sept 2023Mar 2023Dec 2022
RevenueNZD 140.8mNZD 114.0mNZD 121.3mNZD 86.7mNZD 111.8mNZD 83.6mNZD 113.4mNZD 56.7m
Gross profitNZD 61.3mNZD 49.3mNZD 55.5mNZD 36.2mNZD 52.3mNZD 35.9mNZD 55.3mNZD 27.6m
Operating incomeNZD 19.6mNZD 5.3mNZD 19.5m−NZD 1.8mNZD 21.0mNZD 3.3mNZD 20.2mNZD 10.1m
Net incomeNZD 11.5mNZD 3.3mNZD 14.1m−NZD 2.2mNZD 13.8mNZD 1.8mNZD 11.4mNZD 5.7m
Diluted earnings per share0.110.030.13-0.020.130.020.110.09
Cash from operations−NZD 11.0m—NZD 8.0mNZD 4.0mNZD 21.0mNZD 9.0mNZD 7.0mNZD 3.0m
Total assetsNZD 218.6mNZD 170.2mNZD 169.8mNZD 147.9mNZD 165.3mNZD 158.9mNZD 148.1mNZD 184.7m
Cash and short-term investmentsNZD 10.3mNZD 12.1mNZD 11.1mNZD 10.7mNZD 12.0mNZD 6.2mNZD 4.7mNZD 5.9m
DebtNZD 51.6mNZD 34.7mNZD 27.4mNZD 1.2mNZD 29.7mNZD 3.6mNZD 35.2m—
Shareholders' equityNZD 111.1mNZD 98.3mNZD 97.6mNZD 83.8mNZD 87.8mNZD 73.9mNZD 73.3mNZD 91.4m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue17.9%17.8%14.9%
Operating income8.4%18.5%—
Net income11.7%13.8%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin43.4%44.3%44.6%44.1%
Operating margin8.0%9.4%10.2%6.4%
Net margin5.8%6.5%7.6%3.1%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings32.729.620.334.511.961.151.8-103.1-16.6-13.1
Price to sales1.91.71.62.31.84.26.24.12.83.5

Dividends and splits

Per share, in the currency the company pays

Paid for 3 years. Last went ex-dividend on 17 Jun 2026.

FY2027FY2026FY2025FY2024
Paid in the year0.0250.0180.0160.011

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.